Please enable JavaScript to continue using this application.

Compare $PURR vs $RCUS | Chartloom

Compare

$PURR vs $RCUS

Hyperliquid Strategies Inc · Arcus Biosciences Inc

PURR

Hyperliquid Strategies Inc

RCUS

Arcus Biosciences Inc

Compare $PURR vs $RCUS

Comparing Hyperliquid Strategies Inc and Arcus Biosciences Inc

PURRHyperliquid Strategies Inc

RCUSArcus Biosciences Inc

PURRHyperliquid Strategies Inc

Market cap

$1.50B

P/E (TTM)

—

Forward P/E (NTM)

54.46x

Forward P/S (NTM)

31.07x

Rev growth (TTM)

—

YTD performance

223.0%

52W performance

184.9%

FCF yield

-21.6%

RCUSArcus Biosciences Inc

Market cap

$3.07B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

84.08x

Rev growth (TTM)

-55.3%

YTD performance

4.8%

52W performance

62.2%

FCF yield

-15.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

PURR

RCUS

Detailed metrics comparison

PURR

Hyperliquid Strategies Inc

RCUS

Arcus Biosciences Inc

Market Cap

PURR$1.50B

RCUS$3.07B

Enterprise Value

PURR$1.36B

RCUS$3.02B

Price

PURR$11.11

RCUS$24.41

P/E Ratio

PURRN/A

RCUSN/A

P/S Ratio

PURR478.45x

RCUS26.24x

EV/Sales

PURR434.33x

RCUS25.82x

EV/EBITDA

PURR0.00x

RCUS37.63x

P/B Ratio

PURR3.80x

RCUS6.71x

P/FCF Ratio

PURRN/A

RCUSN/A

EV/FCF

PURR-4.21x

RCUS-6.36x

PEG Ratio

PURRN/A

RCUSN/A

Forward P/E (NTM)

PURR54.46x

RCUSN/A

Forward P/S (NTM)

PURR31.07x

RCUS84.08x

Revenue (TTM)

PURR$3M

RCUS$117M

Revenue Growth (YoY)

PURRN/A

RCUS-55.3%

Forward Rev Growth

PURR32.1%

RCUS-34.4%

Gross Margin (TTM)

PURR0.0%

RCUS0.0%

Operating Margin (TTM)

PURR0.0%

RCUS0.0%

EBITDA Margin (TTM)

PURR-41799.5%

RCUS-406.8%

Net Margin (TTM)

PURR-44523.2%

RCUS-393.2%

FCF Margin (TTM)

PURR-10320.0%

RCUS-406.0%

Net Income (TTM)

PURR$-1.39B

RCUS$-460M

FCF (TTM)

PURR$-323M

RCUS$-475M

EPS (TTM)

PURR-$8.94

RCUS-$3.65

ROE (TTM)

PURR0.0%

RCUS-8954.0%

ROA (TTM)

PURR0.0%

RCUS-4561.0%

ROIC (TTM)

PURR0.0%

RCUS-7501.0%

Cash

PURR$138M

RCUS$150M

Debt

PURR$0

RCUS$101M

Net Cash/Debt

PURR$138M

RCUS$49M

Current Ratio (TTM)

PURR41.62x

RCUS3.82x

Quick Ratio (TTM)

PURR37.77x

RCUS3.75x

Debt/Equity (TTM)

PURR0.00x

RCUS0.22x

Debt/Assets (TTM)

PURR0.0%

RCUS0.0%

Interest Coverage (TTM)

PURRN/A

RCUSN/A

Net Debt/EBITDA (TTM)

PURR0.00x

RCUS0.00x

Beta

PURR1.09

RCUS1.05

52W Performance

PURR184.9%

RCUS62.2%

YTD Performance

PURR223.0%

RCUS4.8%

% from 52W High

PURR-24.7%

RCUS-23.1%

% from 52W Low

PURR269.1%

RCUS71.2%

Asset Turnover (TTM)

PURR0.00x

RCUS0.12x

FCF Yield (TTM)

PURR-21.6%

RCUS-15.5%

Earnings Yield (TTM)

PURR-93.1%

RCUS-15.0%

Dividend Yield (TTM)

PURRN/A

RCUSN/A

Rule of 40

PURR-10,320.0

RCUS-461.3

EV/GP/RG

PURRN/A

RCUSN/A

Ticker research

View PURR research View RCUS research

Metric	PURR Hyperliquid Strategies Inc	RCUS Arcus Biosciences Inc
Market & Valuation
Market Cap	$1.50B	$3.07B
Enterprise Value	$1.36B	$3.02B
Price	$11.11	$24.41
P/E Ratio	N/A	N/A
P/S Ratio	478.45x	26.24x
EV/Sales	434.33x	25.82x
EV/EBITDA	0.00x	37.63x
P/B Ratio	3.80x	6.71x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.21x	-6.36x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	54.46x	N/A
Forward P/S (NTM)	31.07x	84.08x
Revenue & Growth
Revenue (TTM)	$3M	$117M
Revenue Growth (YoY)	N/A	-55.3%
Forward Rev Growth	32.1%	-34.4%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-41799.5%	-406.8%
Net Margin (TTM)	-44523.2%	-393.2%
FCF Margin (TTM)	-10320.0%	-406.0%
Net Income (TTM)	$-1.39B	$-460M
FCF (TTM)	$-323M	$-475M
EPS (TTM)	-$8.94	-$3.65
ROE (TTM)	0.0%	-8954.0%
ROA (TTM)	0.0%	-4561.0%
ROIC (TTM)	0.0%	-7501.0%
Financial Health
Cash	$138M	$150M
Debt	$0	$101M
Net Cash/Debt	$138M	$49M
Current Ratio (TTM)	41.62x	3.82x
Quick Ratio (TTM)	37.77x	3.75x
Debt/Equity (TTM)	0.00x	0.22x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.09	1.05
52W Performance	184.9%	62.2%
YTD Performance	223.0%	4.8%
% from 52W High	-24.7%	-23.1%
% from 52W Low	269.1%	71.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.12x
FCF Yield (TTM)	-21.6%	-15.5%
Earnings Yield (TTM)	-93.1%	-15.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-10,320.0	-461.3
EV/GP/RG	N/A	N/A
Ticker research	View PURR research	View RCUS research

Valuation

P/S Ratio

RCUS

26.24x

PURR

478.45x

EV/FCF

RCUS

-6.36x

PURR

-4.21x

Growth & revenue

Revenue Growth TTM

RCUS

-55.3%

Forward Revenue Growth

PURR

32.1%

RCUS

-34.4%

Profitability & performance

Gross Margin

PURR

0.0%

RCUS

0.0%

ROE

PURR

0.0%

RCUS

-8954.0%

FCF Yield %

RCUS

-15.5%

PURR

-21.6%

52-Week Performance

PURR

184.9%

RCUS

62.2%

Detailed metrics comparison

PURR

Hyperliquid Strategies Inc

RCUS

Arcus Biosciences Inc

Market Cap

PURR$1.50B

RCUS$3.07B

Enterprise Value

PURR$1.36B

RCUS$3.02B

Price

PURR$11.11

RCUS$24.41

P/E Ratio

PURRN/A

RCUSN/A

P/S Ratio

PURR478.45x

RCUS26.24x

EV/Sales

PURR434.33x

RCUS25.82x

EV/EBITDA

PURR0.00x

RCUS37.63x

P/B Ratio

PURR3.80x

RCUS6.71x

P/FCF Ratio

PURRN/A

RCUSN/A

EV/FCF

PURR-4.21x

RCUS-6.36x

PEG Ratio

PURRN/A

RCUSN/A

Forward P/E (NTM)

PURR54.46x

RCUSN/A

Forward P/S (NTM)

PURR31.07x

RCUS84.08x

Revenue (TTM)

PURR$3M

RCUS$117M

Revenue Growth (YoY)

PURRN/A

RCUS-55.3%

Forward Rev Growth

PURR32.1%

RCUS-34.4%

Gross Margin (TTM)

PURR0.0%

RCUS0.0%

Operating Margin (TTM)

PURR0.0%

RCUS0.0%

EBITDA Margin (TTM)

PURR-41799.5%

RCUS-406.8%

Net Margin (TTM)

PURR-44523.2%

RCUS-393.2%

FCF Margin (TTM)

PURR-10320.0%

RCUS-406.0%

Net Income (TTM)

PURR$-1.39B

RCUS$-460M

FCF (TTM)

PURR$-323M

RCUS$-475M

EPS (TTM)

PURR-$8.94

RCUS-$3.65

ROE (TTM)

PURR0.0%

RCUS-8954.0%

ROA (TTM)

PURR0.0%

RCUS-4561.0%

ROIC (TTM)

PURR0.0%

RCUS-7501.0%

Cash

PURR$138M

RCUS$150M

Debt

PURR$0

RCUS$101M

Net Cash/Debt

PURR$138M

RCUS$49M

Current Ratio (TTM)

PURR41.62x

RCUS3.82x

Quick Ratio (TTM)

PURR37.77x

RCUS3.75x

Debt/Equity (TTM)

PURR0.00x

RCUS0.22x

Debt/Assets (TTM)

PURR0.0%

RCUS0.0%

Interest Coverage (TTM)

PURRN/A

RCUSN/A

Net Debt/EBITDA (TTM)

PURR0.00x

RCUS0.00x

Beta

PURR1.09

RCUS1.05

52W Performance

PURR184.9%

RCUS62.2%

YTD Performance

PURR223.0%

RCUS4.8%

% from 52W High

PURR-24.7%

RCUS-23.1%

% from 52W Low

PURR269.1%

RCUS71.2%

Asset Turnover (TTM)

PURR0.00x

RCUS0.12x

FCF Yield (TTM)

PURR-21.6%

RCUS-15.5%

Earnings Yield (TTM)

PURR-93.1%

RCUS-15.0%

Dividend Yield (TTM)

PURRN/A

RCUSN/A

Rule of 40

PURR-10,320.0

RCUS-461.3

EV/GP/RG

PURRN/A

RCUSN/A

Ticker research

View PURR research View RCUS research

Metric	PURR Hyperliquid Strategies Inc	RCUS Arcus Biosciences Inc
Market & Valuation
Market Cap	$1.50B	$3.07B
Enterprise Value	$1.36B	$3.02B
Price	$11.11	$24.41
P/E Ratio	N/A	N/A
P/S Ratio	478.45x	26.24x
EV/Sales	434.33x	25.82x
EV/EBITDA	0.00x	37.63x
P/B Ratio	3.80x	6.71x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.21x	-6.36x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	54.46x	N/A
Forward P/S (NTM)	31.07x	84.08x
Revenue & Growth
Revenue (TTM)	$3M	$117M
Revenue Growth (YoY)	N/A	-55.3%
Forward Rev Growth	32.1%	-34.4%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-41799.5%	-406.8%
Net Margin (TTM)	-44523.2%	-393.2%
FCF Margin (TTM)	-10320.0%	-406.0%
Net Income (TTM)	$-1.39B	$-460M
FCF (TTM)	$-323M	$-475M
EPS (TTM)	-$8.94	-$3.65
ROE (TTM)	0.0%	-8954.0%
ROA (TTM)	0.0%	-4561.0%
ROIC (TTM)	0.0%	-7501.0%
Financial Health
Cash	$138M	$150M
Debt	$0	$101M
Net Cash/Debt	$138M	$49M
Current Ratio (TTM)	41.62x	3.82x
Quick Ratio (TTM)	37.77x	3.75x
Debt/Equity (TTM)	0.00x	0.22x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.09	1.05
52W Performance	184.9%	62.2%
YTD Performance	223.0%	4.8%
% from 52W High	-24.7%	-23.1%
% from 52W Low	269.1%	71.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.12x
FCF Yield (TTM)	-21.6%	-15.5%
Earnings Yield (TTM)	-93.1%	-15.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-10,320.0	-461.3
EV/GP/RG	N/A	N/A
Ticker research	View PURR research	View RCUS research